
Huma, a global healthcare AI company founded by Dan Vahdat, has successfully completed its Series D funding round, raising over $80m. This funding will be used to further develop the Huma Cloud Platform, which aims to provide digital-first care and research to individuals worldwide. The platform offers a range of features, including no-code configuration of disease management tools, a library of pre-built modules, and AI integration capabilities. With the completion of the Series D round, Huma has now raised over $300m in total funding, attracting investment from industry leaders such as AstraZeneca and Hitachi Ventures.
The launch of the Huma Cloud Platform represents a significant milestone for the company, enabling the rapid development and deployment of digital health projects.
By leveraging its regulatory status as a configurable FDA Class II and EU MDR Class IIb platform, Huma aims to reduce the time it takes to bring digital health initiatives to market from years to just a few days. The platform's advanced features, such as cloud-agnostic hosting and diagnostic AI algorithms, make it a valuable tool for healthcare providers and researchers looking to streamline their operations and deliver more efficient care.
Huma's collaboration with industry partners like Google and its involvement in major national healthcare projects around the world highlight the company's commitment to advancing digital solutions in healthcare. By combining the Huma Cloud Platform with cutting-edge AI models, Huma aims to expand its reach and impact in the digital care and research space. As Dan Vahdat, Founder and CEO of Huma, notes, the goal is to accelerate the adoption of digital and AI technologies in healthcare, making them accessible and affordable for all. With plans to become profitable this year and continue growing its revenue, Huma is poised to revolutionize the healthcare industry on a global scale.
Click here for a full list of 7,589+ startup investors in the UK